DSM anuncia a expiração do período de espera nos termos da Lei Hart-Scott-Rodino

Heerlen, NL, 01 Feb 2011 08:15 CET

A Royal DSM N.V. (NYSE Euronext: DSM KON), empresa global de Ciências da Vida e Ciências dos Materiais com sede na Holanda, anunciou hoje a expiração do período de espera obrigatório nos termos da Lei Hart-Scott-Rodino Antitrust Improvements Act de 1976, conforme alterada, para sua oferta pública de aquisição de todas as ações ordinárias em circulação da Martek Biosciences Corporation (NASDAQ: MATK) a um preço de US$ 31,50 por ação (a "Oferta").

A Oferta continua sujeita ao recebimento de outras aprovações regulatórias e à satisfação de algumas outras condições. A Oferta está programada para expirar às 17h00 (horário de Nova York) de sexta-feira, 18 de fevereiro de 2011, a menos que a Oferta seja prorrogada.

Martek

Martek is a leader in the innovation, development, production and sale of high-value products from microbial sources that promote health and wellness through nutrition. Martek’s technology platform consists of its core expertise, broad experience and proprietary technology in areas such as microbial biology, algal genomics, fermentation and downstream processing. This technology platform has resulted in Martek’s development of a number of products, including the company’s flagship product, life’sDHA™, a sustainable and vegetarian source of algal DHA (docosahexaenoic acid) important for brain, heart and eye health throughout life for use in infant formula, pregnancy and nursing products, foods and beverages, dietary supplements and animal feeds. Martek also produces life’sARA™ (arachidonic acid), an omega-6 fatty acid, for use in infant formula and follow-on formulas. Martek’s subsidiary, Amerifit Brands, develops, markets and distributes branded consumer health and wellness products and holds

This news release and the description contained herein is neither an offer to purchase nor a solicitation of an offer to sell shares of Martek. On 13 January 2011, DSM and its wholly-owned subsidiary, Greenback Acquisition Corporation, filed a Tender Offer Statement on Schedule TO containing an offer to purchase, a form of letter of transmittal and other documents relating to the tender offer, and Martek filed a Solicitation/Recommendation Statement on Schedule 14D-9 with respect to the tender offer. DSM, Greenback Acquisition Corporation and Martek mailed these documents to the stockholders of Martek. These documents contain important information about the tender offer, and stockholders of Martek are urged to read them carefully. Stockholders of Martek can obtain a free copy of these documents and other documents filed by Martek, DSM or Greenback Acquisition Corporation with the Securities and Exchange Commission at the website maintained by the SEC at www.sec.gov xml-ph-0001@deepl